Differences in the cellular processing of Asp(B10) human insulin compared with human insulin and Lys(B28)Pro(B29) human insulin

Metabolism: Clinical and Experimental

Volumn 48, Issue 5, 1999, Pages 611-617

  Hamel, Frederick G ^a   Siford, Gerri L ^b   Fawcett, Janet ^b   Chance, Ronald E ^b   Frank, Bruce H ^b   Duckworth, William C ^b  

^a VA NEBRASKA WESTERN IOWA HEALTH CARE SYSTEM   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINE DERIVATIVE; INSULIN; INSULIN DERIVATIVE; INSULIN LISPRO; INSULIN[B10 ASPARAGINE]; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ISOLATION; CELLULAR DISTRIBUTION; DOSE TIME EFFECT RELATION; INSULIN METABOLISM; LIVER METABOLISM; MALE; MEAN RESIDENCE TIME; MEMBRANE BINDING; NONHUMAN; PRIORITY JOURNAL;

EID: 0032895627     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(99)90059-8     Document Type: Article

References (29)

1. Brems DN, Alter LA, Beckage MJ, et al: Altering the association properties of insulin by amino acid replacement. Protein Eng 5:527-533, 1992
2. Galloway JA, Chance RE: Improving insulin therapy: Achievements and challenges. Horm Metab Res 26:591-598, 1994
3. Betz JL: Fast-acting human insulin analogs: A promising innovation in diabetes care. Diabetes Educ 21:195-200, 1995
4. DiMarchi RD, Mayer JP, Fan L, et al: Synthesis of a fast-acting insulin based on structural homology with insulin-like growth factor I, in Smith JA, Rivier JE (eds): Peptides - Chemistry and Biology. Proceedings of the Twelfth American Peptide Symposium. Leiden, The Netherlands, ESCOM Science, 1992, pp 26-28
5. Howey DC, Bowsher RR, Brunelle RL, et al: [Lys(B28)Pro(B29)]-human insulin: Effect of injection time on postprandial glycemia. Clin Pharmacol Ther 58:459-469, 1995
6. Pampanelli S, Torlone E, Lalli C, et al: Improved postprandial metabolic control after subcutaneous injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic β-cell function. Diabetes Care 18:1452-1459, 1995.
7. Torlone E, Fanelli C, Rambotti AM, et al: Pharmacokinetics, pharmacodynamics and glucose counterregulation following subcutaneous injection of the monomeric insulin analogue [Lys(B28)Pro(B29)] in IDDM. Diabetologia 37:713-720, 1994
8. Anderson JH Jr, Brunelle RL, Koivisto VA, et al: Reduction of postprandial hyperglycemia and frequency of hypoglycemia in IDDM patients on insulin-analog treatment. Diabetes 46:265-270, 1997
9. Heinemann L, Starke AAR, Heding L, et al: Action profiles of fast onset insulin analogues. Diabetologia 33:384-386, 1990
10. Brange J, Owens DR, Kang S, et al: Monomeric insulins and their experimental and clinical implications. Diabetes Care 13:923-954, 1990
11. Nielsen FS, Jørgensen LN, Ipsen M, et al: Long-term comparison of human insulin analogue B10Asp and soluble human insulin in IDDM patients on a basal/bolus insulin regimen. Diabetologia 38:592-598, 1995
12. Drejer K: The bioactivity of insulin analogues from in vitro receptor binding to in vivo glucose uptake. Diabetes Metab Rev 8:259-286, 1992
13. Jørgensen LN, Dideriksen LH: Preclinical studies of rapid-acting insulin analogues, in Berger M, Gries FA (eds): Frontiers in Insulin Pharmacology. Stuttgart. Germany, Georg Thieme Verlag, 1993, pp 110-117
14. Hansen BF, Danielsen GM, Drejer K, et al: Sustained signalling from the insulin receptor after stimulation with insulin analogues exhibiting increased mitogenic potency. Biochem J 315:271-279, 1996
15. Frank BH, Peavy DE, Hooker CS, et al: Receptor binding properties of monoiodotyrosyl insulin isomers purified by high performance liquid chromatography. Diabetes 32:705-711, 1983
16. Frank BH, Beckage MJ, Willey KA: High-performance liquid chromatographic preparation of single-site carrier-free pancreatic polypeptide hormone radiotracers. J Chromatogr 266:239-248, 1983
17. Peavy DE, Edmondson JW, Duckworth WC: Selective effects of inhibitors of hormone processing on insulin action in isolated hepatocytes. Endocrinology 114:753-760, 1984
18. 125I-insulin by rat hepatocytes. J Biol Chem 250:8389-8398, 1975
19. Duckworth WC, Heinemann MA, Kitabchi AE: Purification of insulin-specific protease by affinity chromatography. Proc Natl Acad Sci USA 69:3698-3702, 1972
20. Hamel FG, Peavy DE, Ryan MP, et al: High performance liquid chromatographic analysis of insulin degradation by rat skeletal muscle insulin protease. Endocrinology 118:328-333, 1986
21. Draznin B, Trowbridge M: Inhibition of intracellular proteolysis by insulin in isolated rat hepatocytes: Possible role of internalized hormone. J Biol Chem 257:11988-11993, 1982
22. Duckworth WC, Bennett RG, Hamel FG: The significance of intracellular insulin to insulin action. J Invest Med 45:20-27, 1997
23. Howey DC, Bowsher RR, Brunelle RL, et al: [Lys(B28)Pro(B29)]-human insulin: A rapidly absorbed analogue of human insulin. Diabetes 43:396-402, 1994
24. Slieker LJ, Brooke GS, Chance RE, et al: Insulin and IGF-I analogs: Novel approaches to improved insulin pharmacokinetics. in LeRoith D, Raizada MK (eds): Current Directions in Insulin-Like Growth Factor Research. New York, NY, Plenum, 1994, pp 25-32
25. Zimmermann JL, Truex LL: 12-Month chronic toxicity study of LY275585 (human insulin analog) administered subcutaneously to Fischer 344 rats. Int J Toxicol 16:639-657, 1997
26. Helton DR. Zimmermann JL, Heim A, et al: General pharmacology of insulin lispro in animals. Arzneimittelforschung 46:91-97, 1996
27. Slieker LJ, Brooke GS, DiMarchi RD, et al: Modifications in the BlO and B26-30 regions of the B chain of human insulin alter affinity for the human IGF-I receptor more than for the insulin receptor. Diabetologia 40:S54-S61, 1997 (suppl 2)
28. Bornfeldt KE, Gidlöf RA, Wasteson A, et al: Binding and biological effects of insulin, insulin analogues and insulin-like growth factors in rat aortic smooth muscle cells. Comparison of maximal growth promoting activities. Diabetologia 34:307-313, 1991
29. Massagué J, Blinderman LA, Czech MP: The high affinity insulin receptor mediates growth stimulation in rat hepatoma cells. J Biol Chem 257:13958-13963, 1982